NCT03365479View on ClinicalTrials.gov

Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

August 1, 2018

Study Completion Date

October 24, 2018

Conditions
Pulmonary HypertensionPulmonary Arterial Hypertension
Interventions
DRUG

Iloprost

Single administration of inhaled iloprost 2.5 μg delivered via Breelib nebulizer

Trial Locations (2)

35392

University Clinic Giessen and Marburg, Giessen

Unknown

Kerckhoff-Klinik, Bad Nauheim

All Listed Sponsors
lead

University of Giessen

OTHER

NCT03365479 - Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter